Global Capmatinib Hydrochloride Tablets Supply, Demand and Key Producers, 2026-2032
The global Capmatinib Hydrochloride Tablets market size is expected to reach $ 1195 million by 2032, rising at a market growth of 12.6% CAGR during the forecast period (2026-2032).
In 2025, global Capmatinib Hydrochloride Tablets production reached approximately 180,000 units.Capmatinib Hydrochloride Tablets are a highly selective mesenchymal–epithelial transition (MET) receptor tyrosine kinase inhibitor and belong to small-molecule oral targeted anticancer drugs. They primarily act by inhibiting the abnormal activation of the MET signaling pathway, thereby blocking tumor cell proliferation, migration, and survival, and play an important role in precision oncology. This drug is mainly used for the treatment of patients with non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations. It is characterized by strong target specificity, proven efficacy, and convenient oral administration, and represents an important therapeutic option in the field of MET-targeted therapies.
Capmatinib Hydrochloride Tablets, as a precision targeted anticancer drug acting on the MET signaling pathway, occupy an important position in the segmented treatment market for non-small cell lung cancer (NSCLC). With the increasing adoption of genetic testing and improved identification of patients with MET exon 14 skipping mutations, the target patient population is gradually expanding, driving steady growth in market demand. Meanwhile, under the trend of precision medicine and personalized therapy, the clinical value of MET inhibitors continues to become more prominent. However, market competition is also intensifying, including from similar MET inhibitors such as Tepotinib as well as other targeted therapies, which pose certain pressures on its market share. Overall, the market for Capmatinib Hydrochloride Tablets represents a “high-value, small-population” niche, with future growth mainly driven by increased diagnostic penetration, expansion of indications, and global market development.
This report studies the global Capmatinib Hydrochloride Tablets production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Capmatinib Hydrochloride Tablets and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Capmatinib Hydrochloride Tablets that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Capmatinib Hydrochloride Tablets total production and demand, 2021-2032, (Units)
Global Capmatinib Hydrochloride Tablets total production value, 2021-2032, (USD Million)
Global Capmatinib Hydrochloride Tablets production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Capmatinib Hydrochloride Tablets consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Capmatinib Hydrochloride Tablets domestic production, consumption, key domestic manufacturers and share
Global Capmatinib Hydrochloride Tablets production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Capmatinib Hydrochloride Tablets production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Capmatinib Hydrochloride Tablets production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Capmatinib Hydrochloride Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Incyte, Sinoway Industrial, Simson Pharma Limited, Hangzhou Jinlan Pharm-Drugs Technology, Dingwang Technology, Beijing SJAR Technology Development, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Capmatinib Hydrochloride Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Capmatinib Hydrochloride Tablets Market, By Region:
1. How big is the global Capmatinib Hydrochloride Tablets market?
2. What is the demand of the global Capmatinib Hydrochloride Tablets market?
3. What is the year over year growth of the global Capmatinib Hydrochloride Tablets market?
4. What is the production and production value of the global Capmatinib Hydrochloride Tablets market?
5. Who are the key producers in the global Capmatinib Hydrochloride Tablets market?
6. What are the growth factors driving the market demand?
In 2025, global Capmatinib Hydrochloride Tablets production reached approximately 180,000 units.Capmatinib Hydrochloride Tablets are a highly selective mesenchymal–epithelial transition (MET) receptor tyrosine kinase inhibitor and belong to small-molecule oral targeted anticancer drugs. They primarily act by inhibiting the abnormal activation of the MET signaling pathway, thereby blocking tumor cell proliferation, migration, and survival, and play an important role in precision oncology. This drug is mainly used for the treatment of patients with non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations. It is characterized by strong target specificity, proven efficacy, and convenient oral administration, and represents an important therapeutic option in the field of MET-targeted therapies.
Capmatinib Hydrochloride Tablets, as a precision targeted anticancer drug acting on the MET signaling pathway, occupy an important position in the segmented treatment market for non-small cell lung cancer (NSCLC). With the increasing adoption of genetic testing and improved identification of patients with MET exon 14 skipping mutations, the target patient population is gradually expanding, driving steady growth in market demand. Meanwhile, under the trend of precision medicine and personalized therapy, the clinical value of MET inhibitors continues to become more prominent. However, market competition is also intensifying, including from similar MET inhibitors such as Tepotinib as well as other targeted therapies, which pose certain pressures on its market share. Overall, the market for Capmatinib Hydrochloride Tablets represents a “high-value, small-population” niche, with future growth mainly driven by increased diagnostic penetration, expansion of indications, and global market development.
This report studies the global Capmatinib Hydrochloride Tablets production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Capmatinib Hydrochloride Tablets and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Capmatinib Hydrochloride Tablets that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Capmatinib Hydrochloride Tablets total production and demand, 2021-2032, (Units)
Global Capmatinib Hydrochloride Tablets total production value, 2021-2032, (USD Million)
Global Capmatinib Hydrochloride Tablets production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Capmatinib Hydrochloride Tablets consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Capmatinib Hydrochloride Tablets domestic production, consumption, key domestic manufacturers and share
Global Capmatinib Hydrochloride Tablets production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Capmatinib Hydrochloride Tablets production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Capmatinib Hydrochloride Tablets production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Capmatinib Hydrochloride Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Incyte, Sinoway Industrial, Simson Pharma Limited, Hangzhou Jinlan Pharm-Drugs Technology, Dingwang Technology, Beijing SJAR Technology Development, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Capmatinib Hydrochloride Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Capmatinib Hydrochloride Tablets Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Genetically Mutated Population
- Advanced or Metastatic Patients
- 150 mg/Tablet
- 200 mg/Tablet
- Innovator
- Originator
- Tablet
- Film-coated Tablet
- Non-Small Cell Lung Cancer (NSCLC)
- MET Exon 14 Skipping Mutation-Positive Patients
- Advanced or Metastatic Lung Cancer
- Others
- Novartis
- Incyte
- Sinoway Industrial
- Simson Pharma Limited
- Hangzhou Jinlan Pharm-Drugs Technology
- Dingwang Technology
- Beijing SJAR Technology Development
1. How big is the global Capmatinib Hydrochloride Tablets market?
2. What is the demand of the global Capmatinib Hydrochloride Tablets market?
3. What is the year over year growth of the global Capmatinib Hydrochloride Tablets market?
4. What is the production and production value of the global Capmatinib Hydrochloride Tablets market?
5. Who are the key producers in the global Capmatinib Hydrochloride Tablets market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Capmatinib Hydrochloride Tablets Introduction
1.2 World Capmatinib Hydrochloride Tablets Supply & Forecast
1.2.1 World Capmatinib Hydrochloride Tablets Production Value (2021 & 2025 & 2032)
1.2.2 World Capmatinib Hydrochloride Tablets Production (2021-2032)
1.2.3 World Capmatinib Hydrochloride Tablets Pricing Trends (2021-2032)
1.3 World Capmatinib Hydrochloride Tablets Production by Region (Based on Production Site)
1.3.1 World Capmatinib Hydrochloride Tablets Production Value by Region (2021-2032)
1.3.2 World Capmatinib Hydrochloride Tablets Production by Region (2021-2032)
1.3.3 World Capmatinib Hydrochloride Tablets Average Price by Region (2021-2032)
1.3.4 North America Capmatinib Hydrochloride Tablets Production (2021-2032)
1.3.5 Europe Capmatinib Hydrochloride Tablets Production (2021-2032)
1.3.6 China Capmatinib Hydrochloride Tablets Production (2021-2032)
1.3.7 Japan Capmatinib Hydrochloride Tablets Production (2021-2032)
1.3.8 India Capmatinib Hydrochloride Tablets Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Capmatinib Hydrochloride Tablets Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Capmatinib Hydrochloride Tablets Major Market Trends
2 DEMAND SUMMARY
2.1 World Capmatinib Hydrochloride Tablets Demand (2021-2032)
2.2 World Capmatinib Hydrochloride Tablets Consumption by Region
2.2.1 World Capmatinib Hydrochloride Tablets Consumption by Region (2021-2026)
2.2.2 World Capmatinib Hydrochloride Tablets Consumption Forecast by Region (2027-2032)
2.3 United States Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.4 China Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.5 Europe Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.6 Japan Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.7 South Korea Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.8 ASEAN Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.9 India Capmatinib Hydrochloride Tablets Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Capmatinib Hydrochloride Tablets Production Value by Manufacturer (2021-2026)
3.2 World Capmatinib Hydrochloride Tablets Production by Manufacturer (2021-2026)
3.3 World Capmatinib Hydrochloride Tablets Average Price by Manufacturer (2021-2026)
3.4 Capmatinib Hydrochloride Tablets Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Capmatinib Hydrochloride Tablets Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Capmatinib Hydrochloride Tablets in 2025
3.5.3 Global Concentration Ratios (CR8) for Capmatinib Hydrochloride Tablets in 2025
3.6 Capmatinib Hydrochloride Tablets Market: Overall Company Footprint Analysis
3.6.1 Capmatinib Hydrochloride Tablets Market: Region Footprint
3.6.2 Capmatinib Hydrochloride Tablets Market: Company Product Type Footprint
3.6.3 Capmatinib Hydrochloride Tablets Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Capmatinib Hydrochloride Tablets Production Value Comparison
4.1.1 United States VS China: Capmatinib Hydrochloride Tablets Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Capmatinib Hydrochloride Tablets Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Capmatinib Hydrochloride Tablets Production Comparison
4.2.1 United States VS China: Capmatinib Hydrochloride Tablets Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Capmatinib Hydrochloride Tablets Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Capmatinib Hydrochloride Tablets Consumption Comparison
4.3.1 United States VS China: Capmatinib Hydrochloride Tablets Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Capmatinib Hydrochloride Tablets Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Capmatinib Hydrochloride Tablets Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Capmatinib Hydrochloride Tablets Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Capmatinib Hydrochloride Tablets Production Value (2021-2026)
4.4.3 United States Based Manufacturers Capmatinib Hydrochloride Tablets Production (2021-2026)
4.5 China Based Capmatinib Hydrochloride Tablets Manufacturers and Market Share
4.5.1 China Based Capmatinib Hydrochloride Tablets Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Capmatinib Hydrochloride Tablets Production Value (2021-2026)
4.5.3 China Based Manufacturers Capmatinib Hydrochloride Tablets Production (2021-2026)
4.6 Rest of World Based Capmatinib Hydrochloride Tablets Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Capmatinib Hydrochloride Tablets Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Capmatinib Hydrochloride Tablets Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Capmatinib Hydrochloride Tablets Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Capmatinib Hydrochloride Tablets Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Genetically Mutated Population
5.2.2 Advanced or Metastatic Patients
5.3 Market Segment by Type
5.3.1 World Capmatinib Hydrochloride Tablets Production by Type (2021-2032)
5.3.2 World Capmatinib Hydrochloride Tablets Production Value by Type (2021-2032)
5.3.3 World Capmatinib Hydrochloride Tablets Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SPECIFICATION
6.1 World Capmatinib Hydrochloride Tablets Market Size Overview by Specification: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Specification
6.2.1 150 mg/Tablet
6.2.2 200 mg/Tablet
6.3 Market Segment by Specification
6.3.1 World Capmatinib Hydrochloride Tablets Production by Specification (2021-2032)
6.3.2 World Capmatinib Hydrochloride Tablets Production Value by Specification (2021-2032)
6.3.3 World Capmatinib Hydrochloride Tablets Average Price by Specification (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
7.1 World Capmatinib Hydrochloride Tablets Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Technology
7.2.1 Innovator
7.2.2 Originator
7.3 Market Segment by Production Technology
7.3.1 World Capmatinib Hydrochloride Tablets Production by Production Technology (2021-2032)
7.3.2 World Capmatinib Hydrochloride Tablets Production Value by Production Technology (2021-2032)
7.3.3 World Capmatinib Hydrochloride Tablets Average Price by Production Technology (2021-2032)
8 MARKET ANALYSIS BY DOSAGE FORM
8.1 World Capmatinib Hydrochloride Tablets Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Dosage Form
8.2.1 Tablet
8.2.2 Film-coated Tablet
8.3 Market Segment by Dosage Form
8.3.1 World Capmatinib Hydrochloride Tablets Production by Dosage Form (2021-2032)
8.3.2 World Capmatinib Hydrochloride Tablets Production Value by Dosage Form (2021-2032)
8.3.3 World Capmatinib Hydrochloride Tablets Average Price by Dosage Form (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Capmatinib Hydrochloride Tablets Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Non-Small Cell Lung Cancer (NSCLC)
9.2.2 MET Exon 14 Skipping Mutation-Positive Patients
9.2.3 Advanced or Metastatic Lung Cancer
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Capmatinib Hydrochloride Tablets Production by Application (2021-2032)
9.3.2 World Capmatinib Hydrochloride Tablets Production Value by Application (2021-2032)
9.3.3 World Capmatinib Hydrochloride Tablets Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Novartis
10.1.1 Novartis Details
10.1.2 Novartis Major Business
10.1.3 Novartis Capmatinib Hydrochloride Tablets Product and Services
10.1.4 Novartis Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Novartis Recent Developments/Updates
10.1.6 Novartis Competitive Strengths & Weaknesses
10.2 Incyte
10.2.1 Incyte Details
10.2.2 Incyte Major Business
10.2.3 Incyte Capmatinib Hydrochloride Tablets Product and Services
10.2.4 Incyte Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Incyte Recent Developments/Updates
10.2.6 Incyte Competitive Strengths & Weaknesses
10.3 Sinoway Industrial
10.3.1 Sinoway Industrial Details
10.3.2 Sinoway Industrial Major Business
10.3.3 Sinoway Industrial Capmatinib Hydrochloride Tablets Product and Services
10.3.4 Sinoway Industrial Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Sinoway Industrial Recent Developments/Updates
10.3.6 Sinoway Industrial Competitive Strengths & Weaknesses
10.4 Simson Pharma Limited
10.4.1 Simson Pharma Limited Details
10.4.2 Simson Pharma Limited Major Business
10.4.3 Simson Pharma Limited Capmatinib Hydrochloride Tablets Product and Services
10.4.4 Simson Pharma Limited Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Simson Pharma Limited Recent Developments/Updates
10.4.6 Simson Pharma Limited Competitive Strengths & Weaknesses
10.5 Hangzhou Jinlan Pharm-Drugs Technology
10.5.1 Hangzhou Jinlan Pharm-Drugs Technology Details
10.5.2 Hangzhou Jinlan Pharm-Drugs Technology Major Business
10.5.3 Hangzhou Jinlan Pharm-Drugs Technology Capmatinib Hydrochloride Tablets Product and Services
10.5.4 Hangzhou Jinlan Pharm-Drugs Technology Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Hangzhou Jinlan Pharm-Drugs Technology Recent Developments/Updates
10.5.6 Hangzhou Jinlan Pharm-Drugs Technology Competitive Strengths & Weaknesses
10.6 Dingwang Technology
10.6.1 Dingwang Technology Details
10.6.2 Dingwang Technology Major Business
10.6.3 Dingwang Technology Capmatinib Hydrochloride Tablets Product and Services
10.6.4 Dingwang Technology Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Dingwang Technology Recent Developments/Updates
10.6.6 Dingwang Technology Competitive Strengths & Weaknesses
10.7 Beijing SJAR Technology Development
10.7.1 Beijing SJAR Technology Development Details
10.7.2 Beijing SJAR Technology Development Major Business
10.7.3 Beijing SJAR Technology Development Capmatinib Hydrochloride Tablets Product and Services
10.7.4 Beijing SJAR Technology Development Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Beijing SJAR Technology Development Recent Developments/Updates
10.7.6 Beijing SJAR Technology Development Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Capmatinib Hydrochloride Tablets Industry Chain
11.2 Capmatinib Hydrochloride Tablets Upstream Analysis
11.2.1 Capmatinib Hydrochloride Tablets Core Raw Materials
11.2.2 Main Manufacturers of Capmatinib Hydrochloride Tablets Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Capmatinib Hydrochloride Tablets Production Mode
11.6 Capmatinib Hydrochloride Tablets Procurement Model
11.7 Capmatinib Hydrochloride Tablets Industry Sales Model and Sales Channels
11.7.1 Capmatinib Hydrochloride Tablets Sales Model
11.7.2 Capmatinib Hydrochloride Tablets Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Capmatinib Hydrochloride Tablets Introduction
1.2 World Capmatinib Hydrochloride Tablets Supply & Forecast
1.2.1 World Capmatinib Hydrochloride Tablets Production Value (2021 & 2025 & 2032)
1.2.2 World Capmatinib Hydrochloride Tablets Production (2021-2032)
1.2.3 World Capmatinib Hydrochloride Tablets Pricing Trends (2021-2032)
1.3 World Capmatinib Hydrochloride Tablets Production by Region (Based on Production Site)
1.3.1 World Capmatinib Hydrochloride Tablets Production Value by Region (2021-2032)
1.3.2 World Capmatinib Hydrochloride Tablets Production by Region (2021-2032)
1.3.3 World Capmatinib Hydrochloride Tablets Average Price by Region (2021-2032)
1.3.4 North America Capmatinib Hydrochloride Tablets Production (2021-2032)
1.3.5 Europe Capmatinib Hydrochloride Tablets Production (2021-2032)
1.3.6 China Capmatinib Hydrochloride Tablets Production (2021-2032)
1.3.7 Japan Capmatinib Hydrochloride Tablets Production (2021-2032)
1.3.8 India Capmatinib Hydrochloride Tablets Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Capmatinib Hydrochloride Tablets Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Capmatinib Hydrochloride Tablets Major Market Trends
2 DEMAND SUMMARY
2.1 World Capmatinib Hydrochloride Tablets Demand (2021-2032)
2.2 World Capmatinib Hydrochloride Tablets Consumption by Region
2.2.1 World Capmatinib Hydrochloride Tablets Consumption by Region (2021-2026)
2.2.2 World Capmatinib Hydrochloride Tablets Consumption Forecast by Region (2027-2032)
2.3 United States Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.4 China Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.5 Europe Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.6 Japan Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.7 South Korea Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.8 ASEAN Capmatinib Hydrochloride Tablets Consumption (2021-2032)
2.9 India Capmatinib Hydrochloride Tablets Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Capmatinib Hydrochloride Tablets Production Value by Manufacturer (2021-2026)
3.2 World Capmatinib Hydrochloride Tablets Production by Manufacturer (2021-2026)
3.3 World Capmatinib Hydrochloride Tablets Average Price by Manufacturer (2021-2026)
3.4 Capmatinib Hydrochloride Tablets Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Capmatinib Hydrochloride Tablets Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Capmatinib Hydrochloride Tablets in 2025
3.5.3 Global Concentration Ratios (CR8) for Capmatinib Hydrochloride Tablets in 2025
3.6 Capmatinib Hydrochloride Tablets Market: Overall Company Footprint Analysis
3.6.1 Capmatinib Hydrochloride Tablets Market: Region Footprint
3.6.2 Capmatinib Hydrochloride Tablets Market: Company Product Type Footprint
3.6.3 Capmatinib Hydrochloride Tablets Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Capmatinib Hydrochloride Tablets Production Value Comparison
4.1.1 United States VS China: Capmatinib Hydrochloride Tablets Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Capmatinib Hydrochloride Tablets Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Capmatinib Hydrochloride Tablets Production Comparison
4.2.1 United States VS China: Capmatinib Hydrochloride Tablets Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Capmatinib Hydrochloride Tablets Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Capmatinib Hydrochloride Tablets Consumption Comparison
4.3.1 United States VS China: Capmatinib Hydrochloride Tablets Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Capmatinib Hydrochloride Tablets Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Capmatinib Hydrochloride Tablets Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Capmatinib Hydrochloride Tablets Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Capmatinib Hydrochloride Tablets Production Value (2021-2026)
4.4.3 United States Based Manufacturers Capmatinib Hydrochloride Tablets Production (2021-2026)
4.5 China Based Capmatinib Hydrochloride Tablets Manufacturers and Market Share
4.5.1 China Based Capmatinib Hydrochloride Tablets Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Capmatinib Hydrochloride Tablets Production Value (2021-2026)
4.5.3 China Based Manufacturers Capmatinib Hydrochloride Tablets Production (2021-2026)
4.6 Rest of World Based Capmatinib Hydrochloride Tablets Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Capmatinib Hydrochloride Tablets Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Capmatinib Hydrochloride Tablets Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Capmatinib Hydrochloride Tablets Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Capmatinib Hydrochloride Tablets Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Genetically Mutated Population
5.2.2 Advanced or Metastatic Patients
5.3 Market Segment by Type
5.3.1 World Capmatinib Hydrochloride Tablets Production by Type (2021-2032)
5.3.2 World Capmatinib Hydrochloride Tablets Production Value by Type (2021-2032)
5.3.3 World Capmatinib Hydrochloride Tablets Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SPECIFICATION
6.1 World Capmatinib Hydrochloride Tablets Market Size Overview by Specification: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Specification
6.2.1 150 mg/Tablet
6.2.2 200 mg/Tablet
6.3 Market Segment by Specification
6.3.1 World Capmatinib Hydrochloride Tablets Production by Specification (2021-2032)
6.3.2 World Capmatinib Hydrochloride Tablets Production Value by Specification (2021-2032)
6.3.3 World Capmatinib Hydrochloride Tablets Average Price by Specification (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
7.1 World Capmatinib Hydrochloride Tablets Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Technology
7.2.1 Innovator
7.2.2 Originator
7.3 Market Segment by Production Technology
7.3.1 World Capmatinib Hydrochloride Tablets Production by Production Technology (2021-2032)
7.3.2 World Capmatinib Hydrochloride Tablets Production Value by Production Technology (2021-2032)
7.3.3 World Capmatinib Hydrochloride Tablets Average Price by Production Technology (2021-2032)
8 MARKET ANALYSIS BY DOSAGE FORM
8.1 World Capmatinib Hydrochloride Tablets Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Dosage Form
8.2.1 Tablet
8.2.2 Film-coated Tablet
8.3 Market Segment by Dosage Form
8.3.1 World Capmatinib Hydrochloride Tablets Production by Dosage Form (2021-2032)
8.3.2 World Capmatinib Hydrochloride Tablets Production Value by Dosage Form (2021-2032)
8.3.3 World Capmatinib Hydrochloride Tablets Average Price by Dosage Form (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Capmatinib Hydrochloride Tablets Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Non-Small Cell Lung Cancer (NSCLC)
9.2.2 MET Exon 14 Skipping Mutation-Positive Patients
9.2.3 Advanced or Metastatic Lung Cancer
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Capmatinib Hydrochloride Tablets Production by Application (2021-2032)
9.3.2 World Capmatinib Hydrochloride Tablets Production Value by Application (2021-2032)
9.3.3 World Capmatinib Hydrochloride Tablets Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Novartis
10.1.1 Novartis Details
10.1.2 Novartis Major Business
10.1.3 Novartis Capmatinib Hydrochloride Tablets Product and Services
10.1.4 Novartis Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Novartis Recent Developments/Updates
10.1.6 Novartis Competitive Strengths & Weaknesses
10.2 Incyte
10.2.1 Incyte Details
10.2.2 Incyte Major Business
10.2.3 Incyte Capmatinib Hydrochloride Tablets Product and Services
10.2.4 Incyte Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Incyte Recent Developments/Updates
10.2.6 Incyte Competitive Strengths & Weaknesses
10.3 Sinoway Industrial
10.3.1 Sinoway Industrial Details
10.3.2 Sinoway Industrial Major Business
10.3.3 Sinoway Industrial Capmatinib Hydrochloride Tablets Product and Services
10.3.4 Sinoway Industrial Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Sinoway Industrial Recent Developments/Updates
10.3.6 Sinoway Industrial Competitive Strengths & Weaknesses
10.4 Simson Pharma Limited
10.4.1 Simson Pharma Limited Details
10.4.2 Simson Pharma Limited Major Business
10.4.3 Simson Pharma Limited Capmatinib Hydrochloride Tablets Product and Services
10.4.4 Simson Pharma Limited Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Simson Pharma Limited Recent Developments/Updates
10.4.6 Simson Pharma Limited Competitive Strengths & Weaknesses
10.5 Hangzhou Jinlan Pharm-Drugs Technology
10.5.1 Hangzhou Jinlan Pharm-Drugs Technology Details
10.5.2 Hangzhou Jinlan Pharm-Drugs Technology Major Business
10.5.3 Hangzhou Jinlan Pharm-Drugs Technology Capmatinib Hydrochloride Tablets Product and Services
10.5.4 Hangzhou Jinlan Pharm-Drugs Technology Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Hangzhou Jinlan Pharm-Drugs Technology Recent Developments/Updates
10.5.6 Hangzhou Jinlan Pharm-Drugs Technology Competitive Strengths & Weaknesses
10.6 Dingwang Technology
10.6.1 Dingwang Technology Details
10.6.2 Dingwang Technology Major Business
10.6.3 Dingwang Technology Capmatinib Hydrochloride Tablets Product and Services
10.6.4 Dingwang Technology Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Dingwang Technology Recent Developments/Updates
10.6.6 Dingwang Technology Competitive Strengths & Weaknesses
10.7 Beijing SJAR Technology Development
10.7.1 Beijing SJAR Technology Development Details
10.7.2 Beijing SJAR Technology Development Major Business
10.7.3 Beijing SJAR Technology Development Capmatinib Hydrochloride Tablets Product and Services
10.7.4 Beijing SJAR Technology Development Capmatinib Hydrochloride Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Beijing SJAR Technology Development Recent Developments/Updates
10.7.6 Beijing SJAR Technology Development Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Capmatinib Hydrochloride Tablets Industry Chain
11.2 Capmatinib Hydrochloride Tablets Upstream Analysis
11.2.1 Capmatinib Hydrochloride Tablets Core Raw Materials
11.2.2 Main Manufacturers of Capmatinib Hydrochloride Tablets Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Capmatinib Hydrochloride Tablets Production Mode
11.6 Capmatinib Hydrochloride Tablets Procurement Model
11.7 Capmatinib Hydrochloride Tablets Industry Sales Model and Sales Channels
11.7.1 Capmatinib Hydrochloride Tablets Sales Model
11.7.2 Capmatinib Hydrochloride Tablets Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Capmatinib HydrochlorideTablets Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Capmatinib HydrochlorideTablets Production Value by Region (2021-2026) & (USD Million)
Table 3. World Capmatinib HydrochlorideTablets Production Value by Region (2027-2032) & (USD Million)
Table 4. World Capmatinib HydrochlorideTablets Production Value Market Share by Region (2021-2026)
Table 5. World Capmatinib HydrochlorideTablets Production Value Market Share by Region (2027-2032)
Table 6. World Capmatinib HydrochlorideTablets Production by Region (2021-2026) & (Units)
Table 7. World Capmatinib HydrochlorideTablets Production by Region (2027-2032) & (Units)
Table 8. World Capmatinib HydrochlorideTablets Production Market Share by Region (2021-2026)
Table 9. World Capmatinib HydrochlorideTablets Production Market Share by Region (2027-2032)
Table 10. World Capmatinib HydrochlorideTablets Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Capmatinib HydrochlorideTablets Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Capmatinib HydrochlorideTablets Major Market Trends
Table 13. World Capmatinib HydrochlorideTablets Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Capmatinib HydrochlorideTablets Consumption by Region (2021-2026) & (Units)
Table 15. World Capmatinib HydrochlorideTablets Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Capmatinib HydrochlorideTablets Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Capmatinib HydrochlorideTablets Producers in 2025
Table 18. World Capmatinib HydrochlorideTablets Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Capmatinib HydrochlorideTablets Producers in 2025
Table 20. World Capmatinib HydrochlorideTablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Capmatinib HydrochlorideTablets Company Evaluation Quadrant
Table 22. World Capmatinib HydrochlorideTablets Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Capmatinib HydrochlorideTablets Production Site of Key Manufacturer
Table 24. Capmatinib HydrochlorideTablets Market: Company Product Type Footprint
Table 25. Capmatinib HydrochlorideTablets Market: Company Product Application Footprint
Table 26. Capmatinib HydrochlorideTablets Competitive Factors
Table 27. Capmatinib HydrochlorideTablets New Entrant and Capacity Expansion Plans
Table 28. Capmatinib HydrochlorideTablets Mergers & Acquisitions Activity
Table 29. United States VS China Capmatinib HydrochlorideTablets Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Capmatinib HydrochlorideTablets Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Capmatinib HydrochlorideTablets Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Capmatinib HydrochlorideTablets Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Capmatinib HydrochlorideTablets Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Capmatinib HydrochlorideTablets Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Capmatinib HydrochlorideTablets Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share (2021-2026)
Table 37. China Based Capmatinib HydrochlorideTablets Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Capmatinib HydrochlorideTablets Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Capmatinib HydrochlorideTablets Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Capmatinib HydrochlorideTablets Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share (2021-2026)
Table 42. Rest of World Based Capmatinib HydrochlorideTablets Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Capmatinib HydrochlorideTablets Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Capmatinib HydrochlorideTablets Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Capmatinib HydrochlorideTablets Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share (2021-2026)
Table 47. World Capmatinib HydrochlorideTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Capmatinib HydrochlorideTablets Production by Type (2021-2026) & (Units)
Table 49. World Capmatinib HydrochlorideTablets Production by Type (2027-2032) & (Units)
Table 50. World Capmatinib HydrochlorideTablets Production Value by Type (2021-2026) & (USD Million)
Table 51. World Capmatinib HydrochlorideTablets Production Value by Type (2027-2032) & (USD Million)
Table 52. World Capmatinib HydrochlorideTablets Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Capmatinib HydrochlorideTablets Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Capmatinib HydrochlorideTablets Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 55. World Capmatinib HydrochlorideTablets Production by Specification (2021-2026) & (Units)
Table 56. World Capmatinib HydrochlorideTablets Production by Specification (2027-2032) & (Units)
Table 57. World Capmatinib HydrochlorideTablets Production Value by Specification (2021-2026) & (USD Million)
Table 58. World Capmatinib HydrochlorideTablets Production Value by Specification (2027-2032) & (USD Million)
Table 59. World Capmatinib HydrochlorideTablets Average Price by Specification (2021-2026) & (US$/Unit)
Table 60. World Capmatinib HydrochlorideTablets Average Price by Specification (2027-2032) & (US$/Unit)
Table 61. World Capmatinib HydrochlorideTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 62. World Capmatinib HydrochlorideTablets Production by Production Technology (2021-2026) & (Units)
Table 63. World Capmatinib HydrochlorideTablets Production by Production Technology (2027-2032) & (Units)
Table 64. World Capmatinib HydrochlorideTablets Production Value by Production Technology (2021-2026) & (USD Million)
Table 65. World Capmatinib HydrochlorideTablets Production Value by Production Technology (2027-2032) & (USD Million)
Table 66. World Capmatinib HydrochlorideTablets Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 67. World Capmatinib HydrochlorideTablets Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 68. World Capmatinib HydrochlorideTablets Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 69. World Capmatinib HydrochlorideTablets Production by Dosage Form (2021-2026) & (Units)
Table 70. World Capmatinib HydrochlorideTablets Production by Dosage Form (2027-2032) & (Units)
Table 71. World Capmatinib HydrochlorideTablets Production Value by Dosage Form (2021-2026) & (USD Million)
Table 72. World Capmatinib HydrochlorideTablets Production Value by Dosage Form (2027-2032) & (USD Million)
Table 73. World Capmatinib HydrochlorideTablets Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 74. World Capmatinib HydrochlorideTablets Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 75. World Capmatinib HydrochlorideTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Capmatinib HydrochlorideTablets Production by Application (2021-2026) & (Units)
Table 77. World Capmatinib HydrochlorideTablets Production by Application (2027-2032) & (Units)
Table 78. World Capmatinib HydrochlorideTablets Production Value by Application (2021-2026) & (USD Million)
Table 79. World Capmatinib HydrochlorideTablets Production Value by Application (2027-2032) & (USD Million)
Table 80. World Capmatinib HydrochlorideTablets Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Capmatinib HydrochlorideTablets Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Novartis Basic Information, Manufacturing Base and Competitors
Table 83. Novartis Major Business
Table 84. Novartis Capmatinib HydrochlorideTablets Product and Services
Table 85. Novartis Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Novartis Recent Developments/Updates
Table 87. Novartis Competitive Strengths & Weaknesses
Table 88. Incyte Basic Information, Manufacturing Base and Competitors
Table 89. Incyte Major Business
Table 90. Incyte Capmatinib HydrochlorideTablets Product and Services
Table 91. Incyte Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Incyte Recent Developments/Updates
Table 93. Incyte Competitive Strengths & Weaknesses
Table 94. Sinoway Industrial Basic Information, Manufacturing Base and Competitors
Table 95. Sinoway Industrial Major Business
Table 96. Sinoway Industrial Capmatinib HydrochlorideTablets Product and Services
Table 97. Sinoway Industrial Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Sinoway Industrial Recent Developments/Updates
Table 99. Sinoway Industrial Competitive Strengths & Weaknesses
Table 100. Simson Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 101. Simson Pharma Limited Major Business
Table 102. Simson Pharma Limited Capmatinib HydrochlorideTablets Product and Services
Table 103. Simson Pharma Limited Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Simson Pharma Limited Recent Developments/Updates
Table 105. Simson Pharma Limited Competitive Strengths & Weaknesses
Table 106. Hangzhou Jinlan Pharm-Drugs Technology Basic Information, Manufacturing Base and Competitors
Table 107. Hangzhou Jinlan Pharm-Drugs Technology Major Business
Table 108. Hangzhou Jinlan Pharm-Drugs Technology Capmatinib HydrochlorideTablets Product and Services
Table 109. Hangzhou Jinlan Pharm-Drugs Technology Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Hangzhou Jinlan Pharm-Drugs Technology Recent Developments/Updates
Table 111. Hangzhou Jinlan Pharm-Drugs Technology Competitive Strengths & Weaknesses
Table 112. Dingwang Technology Basic Information, Manufacturing Base and Competitors
Table 113. Dingwang Technology Major Business
Table 114. Dingwang Technology Capmatinib HydrochlorideTablets Product and Services
Table 115. Dingwang Technology Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Dingwang Technology Recent Developments/Updates
Table 117. Dingwang Technology Competitive Strengths & Weaknesses
Table 118. Beijing SJAR Technology Development Basic Information, Manufacturing Base and Competitors
Table 119. Beijing SJAR Technology Development Major Business
Table 120. Beijing SJAR Technology Development Capmatinib HydrochlorideTablets Product and Services
Table 121. Beijing SJAR Technology Development Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Beijing SJAR Technology Development Recent Developments/Updates
Table 123. Beijing SJAR Technology Development Competitive Strengths & Weaknesses
Table 124. Global Key Players of Capmatinib HydrochlorideTablets Upstream (Raw Materials)
Table 125. Global Capmatinib HydrochlorideTablets Typical Customers
Table 126. Capmatinib HydrochlorideTablets Typical Distributors
Table 1. World Capmatinib HydrochlorideTablets Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Capmatinib HydrochlorideTablets Production Value by Region (2021-2026) & (USD Million)
Table 3. World Capmatinib HydrochlorideTablets Production Value by Region (2027-2032) & (USD Million)
Table 4. World Capmatinib HydrochlorideTablets Production Value Market Share by Region (2021-2026)
Table 5. World Capmatinib HydrochlorideTablets Production Value Market Share by Region (2027-2032)
Table 6. World Capmatinib HydrochlorideTablets Production by Region (2021-2026) & (Units)
Table 7. World Capmatinib HydrochlorideTablets Production by Region (2027-2032) & (Units)
Table 8. World Capmatinib HydrochlorideTablets Production Market Share by Region (2021-2026)
Table 9. World Capmatinib HydrochlorideTablets Production Market Share by Region (2027-2032)
Table 10. World Capmatinib HydrochlorideTablets Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Capmatinib HydrochlorideTablets Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Capmatinib HydrochlorideTablets Major Market Trends
Table 13. World Capmatinib HydrochlorideTablets Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Capmatinib HydrochlorideTablets Consumption by Region (2021-2026) & (Units)
Table 15. World Capmatinib HydrochlorideTablets Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Capmatinib HydrochlorideTablets Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Capmatinib HydrochlorideTablets Producers in 2025
Table 18. World Capmatinib HydrochlorideTablets Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Capmatinib HydrochlorideTablets Producers in 2025
Table 20. World Capmatinib HydrochlorideTablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Capmatinib HydrochlorideTablets Company Evaluation Quadrant
Table 22. World Capmatinib HydrochlorideTablets Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Capmatinib HydrochlorideTablets Production Site of Key Manufacturer
Table 24. Capmatinib HydrochlorideTablets Market: Company Product Type Footprint
Table 25. Capmatinib HydrochlorideTablets Market: Company Product Application Footprint
Table 26. Capmatinib HydrochlorideTablets Competitive Factors
Table 27. Capmatinib HydrochlorideTablets New Entrant and Capacity Expansion Plans
Table 28. Capmatinib HydrochlorideTablets Mergers & Acquisitions Activity
Table 29. United States VS China Capmatinib HydrochlorideTablets Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Capmatinib HydrochlorideTablets Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Capmatinib HydrochlorideTablets Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Capmatinib HydrochlorideTablets Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Capmatinib HydrochlorideTablets Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Capmatinib HydrochlorideTablets Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Capmatinib HydrochlorideTablets Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share (2021-2026)
Table 37. China Based Capmatinib HydrochlorideTablets Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Capmatinib HydrochlorideTablets Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Capmatinib HydrochlorideTablets Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Capmatinib HydrochlorideTablets Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share (2021-2026)
Table 42. Rest of World Based Capmatinib HydrochlorideTablets Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Capmatinib HydrochlorideTablets Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Capmatinib HydrochlorideTablets Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Capmatinib HydrochlorideTablets Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share (2021-2026)
Table 47. World Capmatinib HydrochlorideTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Capmatinib HydrochlorideTablets Production by Type (2021-2026) & (Units)
Table 49. World Capmatinib HydrochlorideTablets Production by Type (2027-2032) & (Units)
Table 50. World Capmatinib HydrochlorideTablets Production Value by Type (2021-2026) & (USD Million)
Table 51. World Capmatinib HydrochlorideTablets Production Value by Type (2027-2032) & (USD Million)
Table 52. World Capmatinib HydrochlorideTablets Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Capmatinib HydrochlorideTablets Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Capmatinib HydrochlorideTablets Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 55. World Capmatinib HydrochlorideTablets Production by Specification (2021-2026) & (Units)
Table 56. World Capmatinib HydrochlorideTablets Production by Specification (2027-2032) & (Units)
Table 57. World Capmatinib HydrochlorideTablets Production Value by Specification (2021-2026) & (USD Million)
Table 58. World Capmatinib HydrochlorideTablets Production Value by Specification (2027-2032) & (USD Million)
Table 59. World Capmatinib HydrochlorideTablets Average Price by Specification (2021-2026) & (US$/Unit)
Table 60. World Capmatinib HydrochlorideTablets Average Price by Specification (2027-2032) & (US$/Unit)
Table 61. World Capmatinib HydrochlorideTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 62. World Capmatinib HydrochlorideTablets Production by Production Technology (2021-2026) & (Units)
Table 63. World Capmatinib HydrochlorideTablets Production by Production Technology (2027-2032) & (Units)
Table 64. World Capmatinib HydrochlorideTablets Production Value by Production Technology (2021-2026) & (USD Million)
Table 65. World Capmatinib HydrochlorideTablets Production Value by Production Technology (2027-2032) & (USD Million)
Table 66. World Capmatinib HydrochlorideTablets Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 67. World Capmatinib HydrochlorideTablets Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 68. World Capmatinib HydrochlorideTablets Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 69. World Capmatinib HydrochlorideTablets Production by Dosage Form (2021-2026) & (Units)
Table 70. World Capmatinib HydrochlorideTablets Production by Dosage Form (2027-2032) & (Units)
Table 71. World Capmatinib HydrochlorideTablets Production Value by Dosage Form (2021-2026) & (USD Million)
Table 72. World Capmatinib HydrochlorideTablets Production Value by Dosage Form (2027-2032) & (USD Million)
Table 73. World Capmatinib HydrochlorideTablets Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 74. World Capmatinib HydrochlorideTablets Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 75. World Capmatinib HydrochlorideTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Capmatinib HydrochlorideTablets Production by Application (2021-2026) & (Units)
Table 77. World Capmatinib HydrochlorideTablets Production by Application (2027-2032) & (Units)
Table 78. World Capmatinib HydrochlorideTablets Production Value by Application (2021-2026) & (USD Million)
Table 79. World Capmatinib HydrochlorideTablets Production Value by Application (2027-2032) & (USD Million)
Table 80. World Capmatinib HydrochlorideTablets Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Capmatinib HydrochlorideTablets Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Novartis Basic Information, Manufacturing Base and Competitors
Table 83. Novartis Major Business
Table 84. Novartis Capmatinib HydrochlorideTablets Product and Services
Table 85. Novartis Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Novartis Recent Developments/Updates
Table 87. Novartis Competitive Strengths & Weaknesses
Table 88. Incyte Basic Information, Manufacturing Base and Competitors
Table 89. Incyte Major Business
Table 90. Incyte Capmatinib HydrochlorideTablets Product and Services
Table 91. Incyte Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Incyte Recent Developments/Updates
Table 93. Incyte Competitive Strengths & Weaknesses
Table 94. Sinoway Industrial Basic Information, Manufacturing Base and Competitors
Table 95. Sinoway Industrial Major Business
Table 96. Sinoway Industrial Capmatinib HydrochlorideTablets Product and Services
Table 97. Sinoway Industrial Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Sinoway Industrial Recent Developments/Updates
Table 99. Sinoway Industrial Competitive Strengths & Weaknesses
Table 100. Simson Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 101. Simson Pharma Limited Major Business
Table 102. Simson Pharma Limited Capmatinib HydrochlorideTablets Product and Services
Table 103. Simson Pharma Limited Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Simson Pharma Limited Recent Developments/Updates
Table 105. Simson Pharma Limited Competitive Strengths & Weaknesses
Table 106. Hangzhou Jinlan Pharm-Drugs Technology Basic Information, Manufacturing Base and Competitors
Table 107. Hangzhou Jinlan Pharm-Drugs Technology Major Business
Table 108. Hangzhou Jinlan Pharm-Drugs Technology Capmatinib HydrochlorideTablets Product and Services
Table 109. Hangzhou Jinlan Pharm-Drugs Technology Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Hangzhou Jinlan Pharm-Drugs Technology Recent Developments/Updates
Table 111. Hangzhou Jinlan Pharm-Drugs Technology Competitive Strengths & Weaknesses
Table 112. Dingwang Technology Basic Information, Manufacturing Base and Competitors
Table 113. Dingwang Technology Major Business
Table 114. Dingwang Technology Capmatinib HydrochlorideTablets Product and Services
Table 115. Dingwang Technology Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Dingwang Technology Recent Developments/Updates
Table 117. Dingwang Technology Competitive Strengths & Weaknesses
Table 118. Beijing SJAR Technology Development Basic Information, Manufacturing Base and Competitors
Table 119. Beijing SJAR Technology Development Major Business
Table 120. Beijing SJAR Technology Development Capmatinib HydrochlorideTablets Product and Services
Table 121. Beijing SJAR Technology Development Capmatinib HydrochlorideTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Beijing SJAR Technology Development Recent Developments/Updates
Table 123. Beijing SJAR Technology Development Competitive Strengths & Weaknesses
Table 124. Global Key Players of Capmatinib HydrochlorideTablets Upstream (Raw Materials)
Table 125. Global Capmatinib HydrochlorideTablets Typical Customers
Table 126. Capmatinib HydrochlorideTablets Typical Distributors
LIST OF FIGURES
Figure 1. Capmatinib HydrochlorideTablets Picture
Figure 2. World Capmatinib HydrochlorideTablets Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Capmatinib HydrochlorideTablets Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 5. World Capmatinib HydrochlorideTablets Average Price (2021-2032) & (US$/Unit)
Figure 6. World Capmatinib HydrochlorideTablets Production Value Market Share by Region (2021-2032)
Figure 7. World Capmatinib HydrochlorideTablets Production Market Share by Region (2021-2032)
Figure 8. North America Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 9. Europe Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 10. China Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 11. Japan Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 12. India Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 13. Capmatinib HydrochlorideTablets Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 16. World Capmatinib HydrochlorideTablets Consumption Market Share by Region (2021-2032)
Figure 17. United States Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 18. China Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 19. Europe Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 20. Japan Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 21. South Korea Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 22. ASEAN Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 23. India Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Capmatinib HydrochlorideTablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Capmatinib HydrochlorideTablets Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Capmatinib HydrochlorideTablets Markets in 2025
Figure 27. United States VS China: Capmatinib HydrochlorideTablets Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Capmatinib HydrochlorideTablets Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Capmatinib HydrochlorideTablets Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share 2025
Figure 31. China Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share 2025
Figure 33. World Capmatinib HydrochlorideTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Capmatinib HydrochlorideTablets Production Value Market Share by Type in 2025
Figure 35. Genetically Mutated Population
Figure 36. Advanced or Metastatic Patients
Figure 37. World Capmatinib HydrochlorideTablets Production Market Share by Type (2021-2032)
Figure 38. World Capmatinib HydrochlorideTablets Production Value Market Share by Type (2021-2032)
Figure 39. World Capmatinib HydrochlorideTablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Capmatinib HydrochlorideTablets Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Figure 41. World Capmatinib HydrochlorideTablets Production Value Market Share by Specification in 2025
Figure 42. 150 mg/Tablet
Figure 43. 200 mg/Tablet
Figure 44. World Capmatinib HydrochlorideTablets Production Market Share by Specification (2021-2032)
Figure 45. World Capmatinib HydrochlorideTablets Production Value Market Share by Specification (2021-2032)
Figure 46. World Capmatinib HydrochlorideTablets Average Price by Specification (2021-2032) & (US$/Unit)
Figure 47. World Capmatinib HydrochlorideTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 48. World Capmatinib HydrochlorideTablets Production Value Market Share by Production Technology in 2025
Figure 49. Innovator
Figure 50. Originator
Figure 51. World Capmatinib HydrochlorideTablets Production Market Share by Production Technology (2021-2032)
Figure 52. World Capmatinib HydrochlorideTablets Production Value Market Share by Production Technology (2021-2032)
Figure 53. World Capmatinib HydrochlorideTablets Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 54. World Capmatinib HydrochlorideTablets Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 55. World Capmatinib HydrochlorideTablets Production Value Market Share by Dosage Form in 2025
Figure 56.Tablet
Figure 57. Film-coatedTablet
Figure 58. World Capmatinib HydrochlorideTablets Production Market Share by Dosage Form (2021-2032)
Figure 59. World Capmatinib HydrochlorideTablets Production Value Market Share by Dosage Form (2021-2032)
Figure 60. World Capmatinib HydrochlorideTablets Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 61. World Capmatinib HydrochlorideTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World Capmatinib HydrochlorideTablets Production Value Market Share by Application in 2025
Figure 63. Non-Small Cell Lung Cancer (NSCLC)
Figure 64. MET Exon 14 Skipping Mutation-Positive Patients
Figure 65. Advanced or Metastatic Lung Cancer
Figure 66. Others
Figure 67. World Capmatinib HydrochlorideTablets Production Market Share by Application (2021-2032)
Figure 68. World Capmatinib HydrochlorideTablets Production Value Market Share by Application (2021-2032)
Figure 69. World Capmatinib HydrochlorideTablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. Capmatinib HydrochlorideTablets Industry Chain
Figure 71. Capmatinib HydrochlorideTablets Procurement Model
Figure 72. Capmatinib HydrochlorideTablets Sales Model
Figure 73. Capmatinib HydrochlorideTablets Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Capmatinib HydrochlorideTablets Picture
Figure 2. World Capmatinib HydrochlorideTablets Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Capmatinib HydrochlorideTablets Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 5. World Capmatinib HydrochlorideTablets Average Price (2021-2032) & (US$/Unit)
Figure 6. World Capmatinib HydrochlorideTablets Production Value Market Share by Region (2021-2032)
Figure 7. World Capmatinib HydrochlorideTablets Production Market Share by Region (2021-2032)
Figure 8. North America Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 9. Europe Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 10. China Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 11. Japan Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 12. India Capmatinib HydrochlorideTablets Production (2021-2032) & (Units)
Figure 13. Capmatinib HydrochlorideTablets Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 16. World Capmatinib HydrochlorideTablets Consumption Market Share by Region (2021-2032)
Figure 17. United States Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 18. China Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 19. Europe Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 20. Japan Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 21. South Korea Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 22. ASEAN Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 23. India Capmatinib HydrochlorideTablets Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Capmatinib HydrochlorideTablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Capmatinib HydrochlorideTablets Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Capmatinib HydrochlorideTablets Markets in 2025
Figure 27. United States VS China: Capmatinib HydrochlorideTablets Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Capmatinib HydrochlorideTablets Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Capmatinib HydrochlorideTablets Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share 2025
Figure 31. China Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Capmatinib HydrochlorideTablets Production Market Share 2025
Figure 33. World Capmatinib HydrochlorideTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Capmatinib HydrochlorideTablets Production Value Market Share by Type in 2025
Figure 35. Genetically Mutated Population
Figure 36. Advanced or Metastatic Patients
Figure 37. World Capmatinib HydrochlorideTablets Production Market Share by Type (2021-2032)
Figure 38. World Capmatinib HydrochlorideTablets Production Value Market Share by Type (2021-2032)
Figure 39. World Capmatinib HydrochlorideTablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Capmatinib HydrochlorideTablets Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Figure 41. World Capmatinib HydrochlorideTablets Production Value Market Share by Specification in 2025
Figure 42. 150 mg/Tablet
Figure 43. 200 mg/Tablet
Figure 44. World Capmatinib HydrochlorideTablets Production Market Share by Specification (2021-2032)
Figure 45. World Capmatinib HydrochlorideTablets Production Value Market Share by Specification (2021-2032)
Figure 46. World Capmatinib HydrochlorideTablets Average Price by Specification (2021-2032) & (US$/Unit)
Figure 47. World Capmatinib HydrochlorideTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 48. World Capmatinib HydrochlorideTablets Production Value Market Share by Production Technology in 2025
Figure 49. Innovator
Figure 50. Originator
Figure 51. World Capmatinib HydrochlorideTablets Production Market Share by Production Technology (2021-2032)
Figure 52. World Capmatinib HydrochlorideTablets Production Value Market Share by Production Technology (2021-2032)
Figure 53. World Capmatinib HydrochlorideTablets Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 54. World Capmatinib HydrochlorideTablets Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 55. World Capmatinib HydrochlorideTablets Production Value Market Share by Dosage Form in 2025
Figure 56.Tablet
Figure 57. Film-coatedTablet
Figure 58. World Capmatinib HydrochlorideTablets Production Market Share by Dosage Form (2021-2032)
Figure 59. World Capmatinib HydrochlorideTablets Production Value Market Share by Dosage Form (2021-2032)
Figure 60. World Capmatinib HydrochlorideTablets Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 61. World Capmatinib HydrochlorideTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World Capmatinib HydrochlorideTablets Production Value Market Share by Application in 2025
Figure 63. Non-Small Cell Lung Cancer (NSCLC)
Figure 64. MET Exon 14 Skipping Mutation-Positive Patients
Figure 65. Advanced or Metastatic Lung Cancer
Figure 66. Others
Figure 67. World Capmatinib HydrochlorideTablets Production Market Share by Application (2021-2032)
Figure 68. World Capmatinib HydrochlorideTablets Production Value Market Share by Application (2021-2032)
Figure 69. World Capmatinib HydrochlorideTablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. Capmatinib HydrochlorideTablets Industry Chain
Figure 71. Capmatinib HydrochlorideTablets Procurement Model
Figure 72. Capmatinib HydrochlorideTablets Sales Model
Figure 73. Capmatinib HydrochlorideTablets Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
